학술논문
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update
Document Type
Article
Author
Reck, M.; Ciuleanu, T.-E.; Cobo, M.; Schenker, M.; Zurawski, B.; Menezes, J.; Richardet, E.; Bennouna, J.; Felip, E.; Juan-Vidal, O.; Alexandru, A.; Sakai, H.; Lingua, A.; Reyes, F.; Souquet, P.-J.; De Marchi, P.; Martin, C.; Pérol, M.; Scherpereel, A.; Lu, S.; Paz-Ares, L.; Carbone, D.P.; Memaj, A.; Marimuthu, S.; Zhang, X.; Tran, P.; John, T.
Source
In ESMO Open October 2021 6(5)
Subject
Language
ISSN
2059-7029